OCALA, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive data in a year-end update from the ongoing Phase 2 clinical ...

GEMINI-Perioperative (PeriOp) Gastric: A phase 2 study of novel agent-based combinations as PeriOp therapy for previously untreated, locally advanced resectable gastric, gastroesophageal junction (GEJ ...

New attack on offshore wind project comes just weeks after greenlight was issued to gas pipeline scheme that was seen as price of lifting previous stop work order Equinor has said it is “evaluating” a ...

New attack on Empire Wind comes just weeks after greenlight was issued to gas pipeline project that was seen as price of lifting previous stop work order against project Equinor has said it is ...

Bitmine Immersion Technologies (BMNR) has been aggressively leaning into its Ethereum bet, steadily buying tokens until it now controls more than 3.2% of the total ETH supply, with leadership openly ...

The head of Xbox Game Studios, Matt Booty, has said that the company is continuing to evaluate how it prices its new releases. Speaking to Variety, the executive said that the firm hoped to "meet ...

Over the past year, Enterprise Products Partners' stock has badly lagged the market. It has also underperformed the S&P 500 over the last three years. Over the last five years, its total return has ...

Vertiv shares were down for much of the past year, but its one-year returns are currently beating the market. Thanks to an amazing 2024, Vertiv's stock generated market-crushing returns for ...

Just a few short weeks ago, Google debuted its Gemini 3 model, claiming it scored a leadership position in multiple AI benchmarks. But the challenge with vendor-provided benchmarks is that they are ...

Hutchmed (China) Limited (Hutchmed), an innovative, commercial-stage, biopharmaceutical company, announced the results from the FRUSICA-2 registration clinical trial of the fruquintinib and sintilimab ...